Financial statements Medical Inventi
Cash inflows of MEDICAL INVENTI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -1 347 566,92 | -1 703 734,44 | -2 448 134,75 | -1 054 567,77 | -3 768 053,57 | -3 640 475,09 |
| Net cash flow from investing activities | -152 200,00 | -129 063,14 | -1 374 168,70 | -10 541,00 | -3 491,87 | -89 321,54 |
| Net cash flow from financial activities | 2 514 284,63 | 3 559 851,27 | 4 558 789,78 | 5 439 097,50 | 872 251,69 | 2 934 680,18 |
| Total net cash flow | 1 014 517,71 | 1 727 053,69 | 736 486,33 | 4 373 988,73 | -2 899 293,75 | -795 116,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.